An Overview of Obesity, Cholesterol, and Systemic Inflammation in Preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Reproductive Immunology
• Metabolic Disorders

Background:

• Preeclampsia (PE) is a major cause of pregnancy complications, leading to maternal and fetal morbidity and mortality.
• Obesity is a significant risk factor for PE, potentially due to impaired placental development and altered metabolic homeostasis.
• Systemic inflammation, hypertension, and adverse pregnancy outcomes in PE are associated with inflammatory cytokines and cholesterol signaling.

Purpose of the Study:

• To review the current understanding of the role of nutrients, obesity, and cholesterol signaling in preeclampsia.
• To emphasize findings from preclinical models investigating the mechanisms underlying PE.
• To synthesize knowledge on factors contributing to PE development and its adverse outcomes.

Main Methods:

• Literature review focusing on preclinical models.
• Analysis of studies investigating nutrient, obesity, and cholesterol impacts on PE.
• Synthesis of data on inflammatory pathways and metabolic dysregulation in PE.

Main Results:

• Obesity and altered metabolic homeostasis contribute to impaired placental development in PE.
• Maternal adipose tissue-derived inflammatory cytokines and circulating cholesterol are implicated in PE pathogenesis.
• Preclinical models provide insights into the mechanisms linking obesity, cholesterol, and PE.

Conclusions:

• Nutrients, obesity, and cholesterol signaling are critical factors in preeclampsia.
• Understanding these factors, particularly from preclinical studies, is essential for mitigating PE risks.
• Further research into these pathways may lead to novel therapeutic strategies for preeclampsia.